Content Title

  • MSKCC
  • The Rockefeller University
  • Weill Cornell Medical College

News

  • September 9, 2014 The Weill Cornell Medical College presents the MILSTEIN PROGRAM IN MEDICINAL CHEMISTRY SYMPOSIUM: FROM TARGET TO TREATMENT
    More
  • Michael A. Foley, Ph.D. December 5, 2013 Accomplished Scientist and Entrepreneur Selected to Lead Tri-Institutional Therapeutics Discovery Institute
    More
  • Tri-Institutional Therapeutics Discovery Institute, Inc. October 1, 2013 Tri-Institutional Therapeutics Discovery Institute, Inc. Launched by Memorial Sloan-Kettering Cancer Center, The Rockefeller University and Weill Cornell Medical College, and Partnership Formed with Takeda
    More

Partners

Takeda

Takeda Pharmaceutical
Company Limited


A global, research-based pharmaceutical company with a strong record for bringing new medicines to market, Takeda will provide medicinal chemists and pharmacologists to work on the development of small molecules.

Facebook iconTwitter iconLinked In icon

 

NewsSeptember 9, 2014 The Weill Cornell Medical College presents the MILSTEIN PROGRAM IN MEDICINAL CHEMISTRY SYMPOSIUM: FROM TARGET TO TREATMENT More December 5, 2013 Accomplished Scientist a